SWOT Analysis for Samrat Pharmachem Ltd.

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Undervalued Growth Stocks
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
MACD crossed above signal line previous end of day
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Declining Net Cash Flow : Companies not able to generate net cash
Fall in Quarterly Revenue and Net Profit (YoY)
Profit to Loss Companies

Companies with Upcoming Results
Companies with improving valuation scores after share price falls

Rising Delivery Percentage Compared to Prev Day
High Delivery Percentage
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)